Concomitant B.I.D. radiotherapy and chemotherapy with cisplatin and 5- fluorouracil in unresectable squamous-cell carcinoma of the pharynx: Clinical and pharmacological data of a French multicenter phase II study

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 2, 1998, Pages 237-245

  Bensadoun, René Jean ^a   Etienne, Marie Christine ^a   Dassonville, Olivier ^a   Chauvel, Pierre ^a   Pivot, Xavier ^a   Marcy, Pierre Yves ^a   Prevost, Bernard ^b   Coche Dequeant, Bernard ^b   Bourdin, Sylvain ^c   Vallicioni, Jacques ^a   Poissonnet, Gilles ^a   Courdi, Adel ^a   Teissier, Eric ^a   Lagrange, Jean Léon ^a   Thyss, A ^a   Santini, José ^d   Demard, François ^a   Schneider, Maurice ^a   Milano, Gérard ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b CENTRE OSCAR LAMBRET   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

B.i.d. radiotherapy; Hypopharynx carcinoma; Oropharynx carcinoma; Pharmacokinetic survey; Radiochemotherapy; Supportive care

Indexed keywords

CISPLATIN; FLUOROURACIL;

AREA UNDER THE CURVE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUTROPENIA; PHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 0032170662     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00235-1     Document Type: Article

References (76)

1. Pinto L.H., Canary P.C., Araujo C.M., et al. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 21:1991;557-562.
2. Horiot J.C., Le Fur R., NGuyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy . Radiother Oncol. 25:1992;231-241.
3. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck The University of Florida experience . Head Neck. 15:1993;87-96.
4. Kish J., Jacobs J., Hoshner J., et al. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of head and neck. Cancer Treat Rep. 66:1982;471-474.
5. Rooney M., Kish J., Jacobs J., et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120 hour 5-FU infusion and cisplatin. Cancer. 55:1985;1123-1128.
6. Thyss A., Schneider M., Santini J., et al. Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer. 54:1986;755-760.
7. Thyss A., Milano G., Renée N., et al. Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer. Cancer Chemother Pharmacol. 16:1986;64-66.
8. Milano G., Etienne M.C., Renée N., et al. Relationship between fluorouracil systemic exposure and tumor response and patient survival. J Clin Oncol. 12:1994;1291-1295.
9. Schneider M., Etienne M.C., Milano G., et al. Phase II trial of cisplatin, fluorouracil and pure l folinic acid for locally advanced head and neck cancer A pharmacokinetic and clinical survey . J Clin Oncol. 13:1995;1656-1662.
10. Vokes E.E., Mick R., Kies M.S., et al. Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. J Clin Oncol. 14:1996;1663-1671.
11. Bellamy A.S., Hill B.T. Interactions between clinically effective antitumor drugs and radiation in experimental systems. Biochem Biophys Acta. 738:1984;125-166.
12. Dewitt L. Combined treatment of radiation and cis-dichlorodiamine platinum (II) A review of experimental and clinical data . Int J Radiat Oncol Biol Phys. 13:1987;403-426.
13. Ciais G., Namer M., Schneider M., et al. La laserthérapie dans la prévention et le traitement des mucites liées à la chimiothérapie anticancéreuse. Bull Cancer. 79:1992;183-191.
14. Pourreau-Schneider N., Soudry M., Franquin J.C., et al. Soft-Laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil A preliminary report . J Natl Cancer Inst. 84:1992;358-359.
15. Cowen D., Tardieu C., Shubert M., et al. Low energy helium/neon laser in the prevention of oral mucositis in patients undergoing bone-marrow transplant Results of a double-blind randomized trial . Int J Radiat Oncol Biol Phys. 38:(4):1997;697-703.
16. Christophidis N., Mihaly G., Vadja F., et al. Comparison of liquid- and gas-liquid chromatographic assays of 5-fluorouracil in plasma. Clin Chem. 25:1979;83-86.
17. Fournier C., Vennin P., Hecquet B. Correlation between free platinum AUC and total platinum measurement 24 hr after i.v. bolus injection of cisplatin in humans. Cancer Chemother Pharmacol. 21:1988;77-77.
18. Eschwège F., Wibault P., Lusinchi A., et al. Treatment of oropharynx carcinomas Experience at the Institut Gustave-Roussy . Recent Results Cancer Res. 134:1994;63-68.
19. Fein D.A., Lee W.R., Amos W.R., et al. Oropharyngeal carcinoma treated with radiotherapy A 30-year experience . Int J Radiat Oncol Biol Phys. 34:1996;289-296.
20. Fu K.K., Cooper J.S., Marcial V.A., et al. Evolution of the Radiation Therapy Oncology Group trials for head and neck cancer. Int J Radiat Oncol Biol Phys. 35:1996;425-438.
21. NGuyen T.D., Panis X., Froissart D., et al. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Int J Radiat Oncol Biol Phys. 14:1988;23-25.
22. Cox J.D., Pajak T.F., Marcial V.A., et al. ASTRO plenary Interfraction interval is a major determinant of late effects with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from RTOG protocol 83-13 . Int J Radiat Oncol Biol Phys. 20:1991;1191-1195.
23. Garden A.S., Morrison W.H., Ang K.K., et al. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck A comparison of two fractionation schedules . Int J Radiat Oncol Biol Phys. 31:1995;493-502.
24. Nyman J., Turesson I. Does the interval between fractions matter in the range of 4-8 h in radiotherapy ? A study of acute and late human skin reactions. Radiother Oncol. 34:1995;171-178.
25. Stuschke M., Thames H.D. Hyperfractionated radiotherapy of human tumors Overview of the randomized clinical trials . Int J Radiat Oncol Biol Phys. 37:1997;259-267.
26. Marcial V.A., Pajak T.F., Mohiuddin M., et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long term results of the RTOG study 81-17. Cancer. 66:1990;1861-1868.
27. Bachaud J.M., David J.M., Boussin G., et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck Preliminary report of a randomized trial . Int J Radiat Oncol Biol Phys. 20:1991;243-246.
28. Forastiere A.A. Cisplatin and radiotherapy in the management of locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 27:1993;465-470.
29. Glaser M.G., Leslie M.D., O'Reilly O., et al. Weekly cisplatinum concomitant with radical radiotherapy in the treatment of advanced head and neck cancer. Clin Oncol. 5:1993;286-289.
30. Glicksman A.S., Slotman G., Doolittle C., et al. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 30:1994;1043-1050.
31. Al-Sarraf M. Cisplatin combinations in the treatment of head and neck cancer. J Clin Oncol. 21:1994;28-34.
32. Zamboglou N., Schnabel T., Kolotas C., et al. Carboplatin and radiotherapy in the treatment of head and neck cancer Six years' experience . Semin Oncol. 21:1994;45-53.
33. Jeremic B., Shibamoto Y., Stanisavljevic B., et al. Radiation therapy alone or concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck A prospective randomized trial . Radiother Oncol. 43:1997;29-37.
34. Eschwège F., Sancho-Garnier H., Gérard J.P., et al. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx Experience of the EORTC . NCI Monograph. 6:1988;275-278.
35. Byfield J.E., Sharp T.R., Frankel S.S., et al. Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol. 2:1984;406-413.
36. Browman G.P., Cripps C., Hodson D.I., et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol. 12:1994;2648-2653.
37. Olver I.N., Hughes P.G., Smith J.G., et al. Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer. Eur J Cancer. 32A:1996;249-254.
38. Vokes E.E., Haraf D.J., Panje W.R., et al. Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer. Semin Oncol. 19:1992;53-58.
39. Weissberg J.B., Son Y.H., Papac R.J., et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys. 17:1989;3-9.
40. Ausili-Cefaro G., Marmiroli L., Salvi G., et al. Concomitant radiation and chemotherapy with mitomycin-C in advanced head and neck cancer. Rays. 18:1993;405-410.
41. Kaplan M.J., Hahn S.S., Johns M.E., et al. Mitomycin and fluorouracil with concomitant radiotherapy in head and neck cancer. Arch Otolaryngol. 111:1985;220-222.
42. Fu K.K., Phillips T.L., Silverberg I.J., et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer Update of a Northern California Oncology Group Randomized Trial . J Clin Oncol. 5:1987;1410-1418.
43. Wendt T.G., Hartenstein R.C., Wustrow T.P.U., et al. Fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer A phase II study . J Clin Oncol. 7:1989;471-476.
44. Denham J.W., Abbot R.L. Concurrent cisplatin, infusional fluorouracil and conventionally fractionated radiation therapy in head and neck cancer Dose-limiting mucosal toxicity . J Clin Oncol. 9:1991;458-463.
45. Dobroswsky W., Dobrowsky E., Strassl H., et al. Combined modality treatment of advanced cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys. 20:1991;239-242.
46. Haraf D.J., Vokes E.E., Weichselbaum R.R., et al. Concomitant chemoradiotherapy with cisplatin, 5 fluorouracil and hydroxyurea in poor-prognosis head and neck cancer. Laryngoscope. 102:1992;630-636.
47. Adelstein D.J., Kalish L.A., Adams G.L., et al. Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer An Eastern Cooperative Oncology Group pilot study . J Clin Oncol. 11:1993;2136-2142.
48. Keane T.J., Cummings B.J., O'Sullivan B., et al. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys. 25:1993;613-618.
49. Smid L., Lesnicar H., Zakotni K., et al. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer. Preliminary report. Int J Radiat Oncol Biol Phys. 32:1995;769-775.
50. Merlano M., Benasso M., Corvo R., et al. Five-year update of alternating chemotherapy and radiotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 88:1996;583-589.
51. El-Sayed S., Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region A meta-analysis of prospective and randomized trials . J Clin Oncol. 14:1996;838-847.
52. Bourhis J., Pignon J.P., Designé L., et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC) (1)Locoregional treatment vs same treatment + chemotherapy (CT) . Proc Am Soc Clin Oncol. 17:1998;386a.
53. Corvo R., Merlano M., Looney W.B., et al. Integration of chemotherapy in an MFD-radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck. Head Neck. 12:1990;60-65.
54. Abitbol A.A., Schwade J.G., Lewin A.A., et al. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study. Am J Clin Oncol. 15:1992;250-255.
55. Weissler M.C., Melin S., Sailer S.L., et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 118:1992;806-810.
56. Brizel D.M., Leopold K.A., Fisher S.R., et al. A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 28:1993;213-220.
57. Leyvraz S., Pasche P., Bauer J., et al. Rapidly alternating chemotherapy and hyperfractioned radiotherapy in the management of locally advanced head and neck carcinoma Four years results of a phase I/II study . J Clin Oncol. 12:1994;1876-1885.
58. Taylor S.G. IV, Murthy A.K., Vannetzel J.M., et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol. 12:1994;385-395.
59. Brizel D.M., Albers M.A., Fisher S.R., et al. A phase III trial of hyperfractionated irradiation +/- concurrent chemotherapy for locally advanced carcinoma of the head and neck Superiority of combined modality treatment . Proc Am Soc Clin Oncol. 16:1997;384a.
60. Calais G., Alfonsi M., Bardet E., et al. Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma (ARCORO). Preliminary results of the 94.01 study from the French group of radiation oncology for head and neck cancer (GORTEC). Proc Am Soc Clin Oncol. 17:1998;385a.
61. Begg A.C. Cisplatin and radiation Interaction probabilities and therapeutic possibilities . Int J Radiat Oncol Biol Phys. 19:1990;1183-1189.
62. Kallman R.F. The importance of schedule and drug dose intensity in combinations of modalities. Int J Radiat Oncol Biol Phys. 28:1994;761-771.
63. Tannock I.F. Treatment of cancer with radiation and drugs. J Clin Oncol. 14:1996;3156-3174.
64. Cox J.D., Pajak T.F., Marcial V.A., et al. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts Preliminary report of RTOG protocol 83-13 . Int J Radiat Oncol Biol Phys. 18:1990;515-521.
65. Duncan W., MacDougall R.H., Kerr G.R., et al. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol. 41:1996;203-207.
66. Bourhis J., Fortin A., Dupuis O., et al. Very accelerated radiation therapy Preliminary results in locally unresectable head and neck carcinomas . Int J Radiat Oncol Biol Phys. 32:1995;747-752.
67. Dische S., Saunders M.I., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
68. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial . Radiother Oncol. 44:1997;111-121.
69. Vokes E.E., Athanasiadis I. Chemotherapy for squamous cell carcinoma of head and neck The future is now . Ann Oncol. 7:1996;15-29.
70. Brockstein B., Haraf D.J., Stenson K., et al. Phase I study of concomitant chemo-radiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol. 16:1998;735-744.
71. Wendt T.G., Grabenbauer G.G., Rödel C.M., et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer A randomized multicenter study . J Clin Oncol. 16:1998;1318-1324.
72. Brockstein B., Haraf D.J., Stenson K., et al. A phase I study of concomitant chemoradiotherapy with one-hour paclitaxel (T), 5-fluorouracil (5-FU) and hydroxyurea (H) with granulocyte colony-stimulating factor (GCSF) support and twice daily (BID) radiotherapy (XRT) for patients with poor prognosis cancer of the head and neck. Proc Am Soc Clin Oncol. 17:1998;394a.
73. Vokes E.E., Schilsky R.L., Weichselbaum R.R., et al. Induction chemotherapy with cisplatin, fluorouracil and high dose leucovorin for locally advanced head and neck cancer A clinical and pharmacologic analysis . J Clin Oncol. 8:1990;241-247.
74. Gouyette A., Apchin A., Foka M., et al. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients. Eur J Cancer Clin Oncol. 22:1986;257-263.
75. Holding J.D., Lindup W.E., Bowdler D.A., et al. Disposition and tumor concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck. Br J Clin Pharmac. 32:1991;173-179.
76. Scanlon K.J., Newman E.M., Priest D.G. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA. 83:1986;8923-8927.